Ovid Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering better, gentler medicines for the brain. It discovers and develops differentiated, small molecule medicines for neurological and neuropsychiatric disorders with significant unmet need. The company was founded by Matthew During and Jeremy M. Levin on April 1, 2014 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
23
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Ovid Therapeutics Inc market cap is $415.21M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ovid Therapeutics Inc 52 week high is $3.11 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ovid Therapeutics Inc 52 week low is $1.26 as of November 22, 2026.
Ovid Therapeutics Inc stock price today is $2.20.
Ovid Therapeutics Inc stock price yesterday was $2.34.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Ovid Therapeutics Inc's P/E ratio is -11.9.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Ovid Therapeutics Inc P/B ratio is 2.0898.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ovid Therapeutics Inc 50-day moving average is $2.46.